dhr. dr. E.B. Cornel

Aandachtsgebieden

CV

Nevenfuncties

BIG-nummer

Wetenschappelijke publicaties en onderzoeken

• What interventions affect the psychosocial burden experienced by prostate cancer patients undergoing active surveillance? A scoping review

  Donachie K, Cornel EB, Pelgrim T, Michelsen L, Langenveld B, Adriaansen M, Bakker E, Lechner L.
  Support Care Cancer 2022; 30(6):4699-4709.
  

• Argus-T adjustable male sling: A follow-up study on urinary incontinence and patient's satisfaction

  Casteleijn NF(ZGT), Cornel EB.
  Neurourol Urodyn . 2021; 40(3):802-9.
  

• Optimizing the risk threshold of lymph node involvement for performing extended pelvic lymph node dissection in prostate cancer patients: a cost-effectiveness analysis

  Hueting TTA, Cornel EB, Korthorst RRA, Pleijhuis RRG, Somford DDM, Basten JPA van, Palen JJ van der, Koffijberg HH.
  Urol Oncol. 2020; :doi: 10.1016/j.urolonc.2020.09.014. Online ahead of print..
  

• No need to say goodbye to transrectal biopsies in the diagnostic work-up for prostate cancer

  Casteleijn NF(ZGT), Veltman J, Braak SJ, Cornel EB.
  World J Urol. 2020; :doi: 10.1007/s00345-020-03374-x. Online ahead of print..
  

• Development and usability testing of a multi-criteria value clarification methods for patients with localized prostate cancer

  Angst IB de , Weernink MG, Kil PJ, Til JA van , Cornel EB, Takkenberg JJ.
  Health Infomatics J. 2020; 26(1):486-498.
  

• The Usefulness of the Modified Frailty Index for Muscle-Invasive Bladder Cancer Patients Treated with Radical Cystectomy

  Voskamp MJH, Verhagen T, Molijn GJ, Cornel EB.
  Curr Urol. 2020; 14(1):32-37.
  

• Focal Salvage MR Imaging-Guided Cryoablation for Localized Prostate Cancer Recurrence After Radiotherapy: 12-Month Follow-up

  Bomers JGR, Overduin CG, Jenniskins SFM, Cornel EB.
  J. Vasc. Intervent. Radiol. 2020; 1:35-41.
  

• Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial

  Witjes JA, Morote J, Cornel EB, Gakis G, Valenberg FJ van, Lozano F, Sternberg JA, Willemsen E, Hegemann ML.
  Eur Urol Oncol. 2019; 1(4)::307-313.
  

• High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility

  Leest M van der , Israël B, Cornel EB, Zámecnik P, Schoots IG, Lelij H van der , Padhani AR, Veltman J.
  Eur Urol. 2019; :doi: 10.1016/j.eururo.2019.05.029. [Epub ahead of print].
  Publicatie openen

• Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance

  Leest M van der , Cornel EB, Israël B, Hendriks R, Padhani AR, Hoogenboom M, Zamecnik P, Bakker D, Setiasti AY, Veltman J, Hout JH van den.
  Eur Urol. 2018; :doi: 10.1016/j.eururo.2018.11.023. [Epub ahead of print].
  Publicatie openen

• Position paper: de medisch specialist in de rol van wetenschapper

  
  Publicatie openen

• Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial.

  Doeveren T van , Leeuwen PJ van , Aben KK, Aa M van der, Barendrecht M, Boevé ER, Cornel EB, Heijden AG van der , Hendricksen K.
  Contemp Clin Trials Commun. 2018; 9:121-129.
  Publicatie openen

• The impact of prostate cancer diagnosis and treatment decision-making on health-related quality of life before treatment onset

  Cuypers M, Lamers RE, Cornel EB, Poll-Franse LV van de, Vries M de , Kil PJ.
  Support Care Cancer. 2017; :doi: 10.1007/s00520-017-3953-8.
  Publicatie openen

• Waarde van het multidisciplinair uro-oncologisch overleg

  Pellikaan LK, Vriesema JLJ, Brusse-Keizer MG, Cornel EB.
  Ned Tijdschr Geneeskd 2017; 159:A8590.
  Publicatie openen

• Clinical Outcomes and Testosterone Levels Following Continuous Androgen Deprivation in Patients with Relapsing or Locally Advanced Prostate Cancer

  Tombal B, Cornel EB, Persad R, Stari A, Gomez Veiga F, Schulman C.
  J Urol 2017; :10.1016/j.juro.2017.05.072.
  Publicatie openen

• MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imaging

  Bomers JG, Cornel EB, Fütterer JJ, Jenniskens SF, Schaafsma HE, Barentsz JO, Sedelaar JP, Hulsbergen-van de Kaa CA, Witjes JA.
  World J Urol 2017; 35(5):703-711.
  Publicatie openen

• The effect of office based flexible and rigid cystoscopy on pain experience in female patients

  Casteleijn NF, Vriesema JLJ, Stomps SP, Cornel EB, Balen OLWB van.
  Investig Clin Urol 2017; 58 (1):48-53.
  Publicatie openen

• Validatie van een nieuwe urinetest voor klinisch significante prostaatkanker

  Hendriks RJ, Dijkstra S, Cornel EB, Jannink SA, Jong H de, Hessels D, Smit FP, Melchers JW, Leyten G, Reijke TM de, Vergunst H, Kil P, Knipscheer BC, Hulsbergen-van de Kaa CA, Mulders PF, Oort IM van, Schalken JA, .
  Tijdschr Urol. 2016; 6:34-43.
  Publicatie openen

• MR-targeted TRUS prostate biopsy using local reference augmentation: initial experience

  Ven WJ van de, Venderink W, Sedelaar JP, Veltman J, Barentsz JO, Fütterer JJ, Cornel EB, Huisman HJ, Veltman J, Veltman J, .
  Int Urol Nephrol. 2016; :.
  Publicatie openen

• Intermittent versus continuous androgen deprivation therapy in patients with relapsing or locally advanced prostate cancer: a phase 3b randomized study (ICELAND)

  Schulman C, Cornel EB, Matveev V, Tammela TL, Schraml J, Bensadoun H, Warnack W, Persad R, Salagierski M, Gómez Veiga F, Baskin-Bey E, López B, Tombal B.
  Eur Urol 2016; 69(4):720-7.
  Publicatie openen

• The clinical impact of routine bladder biopsy after BCG treatment of high grade non muscle invasive bladder cancer

  Jong IJ de, Jonker LT, Weerink MA, Cornel EB, Luijendijk D, Leliveld AM.
  J Clin Oncol 2016; 34(2):S438.
  

• Argus-T Adjustable Male Sling: The Influence of Surgical Technique on Complications and Short-Term Efficacy

  Cornel EB.
  Urol Int 2016; 96(2):164-70.
  Publicatie openen

• Value of a multidisciplinary team for patients with a urological malignancy

  Pelikaan L, Vriesema JL, Brusse-Keizer MG, Cornel EB.
  Ned Tijdschr Geneeskd 2015; 159:A8590.
  Publicatie openen

• Het niet-spierinvasieve blaascarcinoom: een retrospectieve kwaliteitscontrolestudie

  Casteleijn NF, Hakvoort DM, Peper H, Palen J van der, Cornel EB.
  Tijdschrift Urol 2014; (8):178-184.
  

• Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer

  Leyten GH, Hessels D, Jannink SA, Smit FP, Jong H de, Cornel EB, Reijke TM de, Vergunst H, Kil P, Knipscheer BC, Oort IM van, Mulders PF, Hulsbergen-van de Kaa CA, Schalken JA.
  Eur Urol 2014; 65(3):534-42. doi: 10.1016/j.eururo.2012.11.014. Epub 2012 Nov 15.
  Publicatie openen

• Results of a phase 1 dose escalation study of intravesical TMX-101 in patients with nonmuscle invasive bladder cancer

  Falke J, Lammers RJ, Arentsen HC, Ravic M, Pozzi R, Cornel EB, Vergunst H, Reijke TM de, Witjes JA.
  J Urol 2013; 189(6):2077-82.
  Publicatie openen

• Active surveillance for low-risk prostate cancer worldwide: the PRIAS study

  Bul M, Zhu X, Valdagni R, Pickles T, Kakehi Y, Rannikko A, Bjartell A, Schoot DK van der, Cornel EB, Conti GN, Boevé ER, Staerman F, Vis-Maters JJ, Vergunst H, Jaspars JJ, Strölin P, Muilekom E van, Schröder FH, Bangma CH, Roobol MJ.
  Eur Urol 2013; 63(4):597-603.
  Publicatie openen

• Epidermoide cyste van de testis: a case report

  Pellikaan LK, Vriesema JL, Cornel EB.
  Tijdschr Urol 2012; 6:.
  

• Contemporary role of androgen deprivation therapy for prostate cancer (first of two parts)

  Cornel EB.
  Eur Urol 2012; 61(6):e59, author reply e60.
  

• Phase 2 study of adjuvant intravesical instillations of apaziquone for high risk nonmuscle invasive bladder cancer

  Hendricksen K, Cornel EB, Reijke TM de, Arentsen HC, Chawla S, Witjes JA.
  J Urol 2012; 187(4):1195-9.
  Publicatie openen